A phase Ib trial of LHF-535 in patients

Trial Profile

A phase Ib trial of LHF-535 in patients

Planning
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2016

At a glance

  • Drugs LHF 535 (Primary)
  • Indications Lassa fever
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Jun 2016 New trial record
    • 05 May 2016 According to a Kineta media release, this trial will be funded by an award of $7.2M from Wellcome Trust.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top